Health
Investigational Alzheimer’s drug reduces molecular markers of the disease – News-Medical.Net
An investigational Alzheimer’s drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating…
An investigational Alzheimer’s drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating evidence of cognitive benefit, in a phase 2/3 clinical trial led by researchers at Washington University School of…
Continue Reading
-
Noosa News21 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business21 hours agoDicker Data rides the AI trend to double digit growth
-
Business24 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy
-
Noosa News21 hours agoBob Katter threatens Channel 9 journalist for asking question on family heritage